![Perimenopause: Tackling the dearth of treatments for anxiety and depression - Pharmaceutical Technology Perimenopause: Tackling the dearth of treatments for anxiety and depression - Pharmaceutical Technology](https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2023/03/GettyImages-1303341351.jpg)
Perimenopause: Tackling the dearth of treatments for anxiety and depression - Pharmaceutical Technology
![Essential Reads: Who is at Risk for Depression During the Perimenopause? - MGH Center for Women's Mental Health Essential Reads: Who is at Risk for Depression During the Perimenopause? - MGH Center for Women's Mental Health](https://womensmentalhealth.org/wp-content/uploads/2020/12/older-woman-in-yellow-shirt-scaled.jpg)
Essential Reads: Who is at Risk for Depression During the Perimenopause? - MGH Center for Women's Mental Health
![Biomedicines | Free Full-Text | Menopause-Associated Depression: Impact of Oxidative Stress and Neuroinflammation on the Central Nervous System—A Review Biomedicines | Free Full-Text | Menopause-Associated Depression: Impact of Oxidative Stress and Neuroinflammation on the Central Nervous System—A Review](https://www.mdpi.com/biomedicines/biomedicines-12-00184/article_deploy/html/images/biomedicines-12-00184-g001-550.jpg)
Biomedicines | Free Full-Text | Menopause-Associated Depression: Impact of Oxidative Stress and Neuroinflammation on the Central Nervous System—A Review
![Antidepressants during and after Menopausal Transition: A Systematic Review and Meta-Analysis | Scientific Reports Antidepressants during and after Menopausal Transition: A Systematic Review and Meta-Analysis | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-64910-8/MediaObjects/41598_2020_64910_Fig1_HTML.png)